Richard King - Net Worth and Insider Trading
Richard King Net Worth
The estimated net worth of Richard King is at least $407,690 dollars as of 2024-09-19. Richard King is the COO of Adamas Pharmaceuticals Inc and owns about 48,856 shares of Adamas Pharmaceuticals Inc (ADMS) stock worth over $401,596. Richard King is also the CEO of Talphera Inc and owns about 6,348 shares of Talphera Inc (TLPH) stock worth over $6,094. Details can be seen in Richard King's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Richard King has not made any transactions after 2018-06-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Richard King
Richard King Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Richard King owns 3 companies in total, including Spruce Biosciences Inc (SPRB) , Adamas Pharmaceuticals Inc (ADMS) , and Talphera Inc (TLPH) .
Click here to see the complete history of Richard King’s form 4 insider trades.
Insider Ownership Summary of Richard King
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SPRB | Spruce Biosciences Inc | 2020-10-08 | director & Chief Executive Officer |
| ADMS | Adamas Pharmaceuticals Inc | 2018-06-21 | Chief Operating Officer |
| TLPH | Talphera Inc | 2011-06-09 | director & President and CEO |
Richard King Latest Holdings Summary
Richard King currently owns a total of 2 stocks. Among these stocks, Richard King owns 48,856 shares of Adamas Pharmaceuticals Inc (ADMS) as of June 21, 2018, with a value of $401,596 and a weighting of 98.51%. Richard King also owns 6,348 shares of Talphera Inc (TLPH) as of June 9, 2011, with a value of $6,094 and a weighting of 1.49%.
Latest Holdings of Richard King
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ADMS | Adamas Pharmaceuticals Inc | 2018-06-21 | 48,856 | 8.22 | 401,596 |
| TLPH | Talphera Inc | 2011-06-09 | 6,348 | 0.96 | 6,094 |
Holding Weightings of Richard King
Richard King Form 4 Trading Tracker
According to the SEC Form 4 filings, Richard King has made a total of 0 transactions in Adamas Pharmaceuticals Inc (ADMS) over the past 5 years. The most-recent trade in Adamas Pharmaceuticals Inc is the sale of 2,501 shares on June 21, 2018, which brought Richard King around $63,726.
According to the SEC Form 4 filings, Richard King has made a total of 0 transactions in Talphera Inc (TLPH) over the past 5 years. The most-recent trade in Talphera Inc is the acquisition of 175 shares on June 9, 2011, which cost Richard King around $15,960.
Insider Trading History of Richard King
- 1
Richard King Trading Performance
GuruFocus tracks the stock performance after each of Richard King's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Richard King is -30.49%. GuruFocus also compares Richard King's trading performance to market benchmark return within the same time period. The performance of stocks bought by Richard King within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Richard King's insider trading performs compared to the benchmark.
Performance of Richard King
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -9.38 | | | | | |
| Relative Return to S&P 500(%) | -13.63 | | | | | |
Richard King Ownership Network
Richard King Owned Company Details
What does Spruce Biosciences Inc do?
Who are the key executives at Spruce Biosciences Inc?
Richard King is the director & Chief Executive Officer of Spruce Biosciences Inc. Other key executives at Spruce Biosciences Inc include 10 percent owner Novo Holdings A/s , Chief Medical Officer Charlton Ralph William Iii , and director & Chief Executive Officer Javier B. Szwarcberg .
Spruce Biosciences Inc (SPRB) Insider Trades Summary
Over the past 18 months, Richard King made no insider transaction in Spruce Biosciences Inc (SPRB). Other recent insider transactions involving Spruce Biosciences Inc (SPRB) include a net sale of 4,172,336 shares made by Novo Holdings A/s ,
In summary, during the past 3 months, insiders sold 0 shares of Spruce Biosciences Inc (SPRB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,172,336 shares of Spruce Biosciences Inc (SPRB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,172,336 shares.
Spruce Biosciences Inc (SPRB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Spruce Biosciences Inc Insider Transactions
Richard King Mailing Address
Above is the net worth, insider trading, and ownership report for Richard King. You might contact Richard King via mailing address: C/o Kos Pharmaceuticals Inc, 1001 Brickell Ave 25th Fl, Miami Fl 33131.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
